Sanofi’s jump in earnings comes with an increased emphasis on R&D and vaccines, plus an eye cast toward M&A to shore up its pipeline.

In 2024, the Center for Disease Control and Prevention (CDC) announced that cases of meningitis were on the rise in the US. In particular, there were increasing reports of a type of bacterial ...